Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
Anti-MMP-2 Antibody (5E993) is a Rabbit antibody targeting MMP-2. Anti-MMP-2 Antibody (5E993) can be used in ELISA.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 20 μL | $94 | 7-10 days | |
| 100 μL | $292 | 7-10 days | 
| Description | Anti-MMP-2 Antibody (5E993) is a Rabbit antibody targeting MMP-2. Anti-MMP-2 Antibody (5E993) can be used in ELISA. | 
| Synonyms | MMP-2, matrix metallopeptidase 2, GelA, Clg4a | 
| Ig Type | Rabbit IgG | 
| Clone | 5E993 | 
| Reactivity | Human | 
| Specificity | Human MMP-2 No cross-reactivity in ELISA with Human MMP1 Human MMP9 Human MMP8 | 
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000 | 
| Antibody Type | Monoclonal | 
| Host Species | Rabbit | 
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human MMP-2 (rh MMP-2; TMPY-01477; NP_004521.1; Met 1-Cys660). | 
| Purification | Protein A | 
| Appearance | Liquid | 
| Formulation | 0.2 μm filtered solution in PBS | 
| Research Background | Matrix Metalloproteinase-2 (MMP-2) is an enzyme that degrades components of the extracellular matrix and thus plays a pivotal role in cell migration during physiological and pathological processes. MMP-2 expression is dependent on extracellular matrix metalloproteinase inducer (EMMPRIN), Her2/neu, growth factors, cytokines, and hormones. Pro-MMP-2 activation needs MT1-MMP and TIMP-2 contribution. MMP-2 is changed in distribution and increased in amount in the ventral cochlear nucleus after unilateral cochlear ablation. A low level of MMP-2 is linked to a favorable prognosis in patients with a hormone receptor-negative tumor, usually associated with high risk. As a zymogen requiring proteolytic activation for catalytic activity, MMP-2 has been implicated broadly in the invasion and metastasis of many cancer model systems, including human breast cancer (HBC). Blocking MMP-2 secretion and activation during breast carcinoma development may decrease metastasis. The detection of active MMP-2 alone or the rate of pro-MMP-2 and active MMP-2 is considered a very sensitive indicator of cancer metastasis. Modulation of MMP-2 expression and activation through specific inhibitors and activators may thus provide a new mechanism for breast cancer treatment. | 
| Conjucates | Unconjugated | 
| Immunogen | Recombinant Protein: Human MMP-2 protein (TMPY-01477) | 
| Antigen Species | Human | 
| Biology Area | Cancer Drug Targets | 
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. | 
| Transport | Shipping with blue ice. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.